Analysis of RNA sequencing data from 516 lung adenocarcinoma and 59 normal tissue samples in The Cancer Genome Atlas (TCGA) revealed significantly higher RPL35A expression in tumor tissues compared to normal controls (Fig. 1A). This evidence concerns the gene RPL35A and neoplasm.